Interleukin-27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromal cell treatment

Journal of Autoimmunity

Volumn 30, Issue 4, 2008, Pages 222-229

  Wang, Jinghua ^a   Wang, Guangyou ^a   Sun, Bo ^a   Li, Hulun ^a   Mu, Lili ^a   Wang, Qi ^a   Li, Guozhong ^a   Shi, Lijun ^a   Jin, Lianhong ^a   Kostulas, Nikolaos ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone marrow stromal cells; Experimental autoimmune encephalomyelitis; Immunoregulation; Interleukin 17; Interleukin 27

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 27;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL LINE; CELL STIMULATION; CELL THERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STROMA CELL;

EID: 42249115211     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.10.001     Document Type: Article

References (40)

1. Schrempf W., and Ziemssen T. Glatiramer acetate: mechanisms of action in multiple sclerosis. Autoimmun Rev 6 (2007) 469-475
2. Gonnella P.A., Chen Y.H., Waldner H., and Weiner H.L. Induction of oral tolerization in CD86 deficient mice: a role for CD86 and B cells in the up-regulation of TGF-beta. J Autoimmun 26 (2006) 73-81
3. Nicholson L.B., and Kuchroo V.K. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr Opin Immunol 8 (1996) 837-842
4. Rosloniec E.F., Brandstetter T., Leyer S., Schwaiger F.W., and Nagy Z.A. Second-generation peptidomimetic inhibitors of antigen presentation effectively treat autoimmune diseases in HLA-DR-transgenic mouse models. J Autoimmun 27 (2006) 182-195
5. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 (2005) 233-240
6. Furuzawa-Carballeda J., Vargas-Rojas M.I., and Cabral A.R. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6 (2007) 169-175
7. Bailey S.L., Schreiner B., McMahon E.J., and Miller S.D. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4(+) T(H)-17 cells in relapsing EAE. Nat Immunol 8 (2007) 172-180
8. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
9. Liu Z., Jiu J., Liu S., Fa X., Li F., and Du Y. Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion. J Autoimmun 29 (2007) 187-194
10. Colgan J., and Rothman P. All in the family: IL-27 suppression of T(H)-17 cells. Nat Immunol 7 (2006) 899-901
11. Derubeis A.R., and Cancedda R. Bone marrow stromal cells (BMSCs) in bone engineering: limitations and recent advances. Ann Biomed Eng 32 (2004) 160-165
12. Hung S.C., Chen N.J., Hsieh S.L., Li H., Ma H.L., and Lo W.H. Isolation and characterization of size-sieved stem cells from human bone marrow. Stem Cells 20 (2002) 249-258
13. Aoki C.A., Roifman C.M., Lian Z.X., Bowlus C.L., Norman G.L., Shoenfeld Y., et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 27 (2006) 50-53
14. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 (2002) 3838-3843
15. Glennie S., Soeiro I., Dyson P.J., Lam E.W., and Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105 (2005) 2821-2827
16. Augello A., Tasso R., Negrini S.M., Amateis A., Indiveri F., Cancedda R., et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 35 (2005) 1482-1490
17. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106 (2005) 1755-1761
18. Rasmusson I. Immune modulation by mesenchymal stem cells. Exp Cell Res 312 (2006) 2169-2179
19. Uccelli A., Moretta L., and Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36 (2006) 2566-2573
20. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815-1822
21. Silva W.A., Covas D.T., Panepucci R.A., Proto-Siqueira R., Siufi J.L., Zanette D.L., et al. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 21 (2003) 661-669
22. Li H., Yu B., Zhang Y., Pan Z., Xu W., and Li H. Jagged1 protein enhances the differentiation of mesenchymal stem cells into cardiomyocytes. Biochem Biophys Res Commun 341 (2006) 320-325
23. Li H.L., Liu J.Q., Bai X.F., van der Meide P.H., and Link H. Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats. Immunology 94 (1998) 431-437
24. Rouvier E., Luciani M.F., Mattei M.G., Denizot F., and Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 150 (1993) 5445-5456
25. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 177 (2006) 566-573
26. Seko Y., Cole S., Kasprzak W., Shapiro B.A., and Ragheb J.A. The role of cytokine mRNA stability in the pathogenesis of autoimmune disease. Autoimmun Rev 5 (2006) 299-305
27. Fossiez F., Banchereau J., Murray R., Van Kooten C., Garrone P., and Lebecque S. Interleukin-17. Int Rev Immunol 16 (1998) 541-551
28. Abbas A.K., Lohr J., and Knoechel B. Balancing autoaggressive and protective T cell responses. J Autoimmun 28 (2007) 59-61
29. Hofstetter H.H., Ibrahim S.M., Koczan D., Kruse N., Weishaupt A., Toyka K.V., et al. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 237 (2005) 123-130
30. Rohn T.A., Jennings G.T., Hernandez M., Grest P., Beck M., Zou Y., et al. Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur J Immunol 36 (2006) 2857-2867
31. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141
32. Tutaj M., and Szczepanik M. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE). J Autoimmun 28 (2007) 208-215
33. Smith C.E., and Miller S.D. Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities. J Autoimmun 27 (2006) 218-231
34. Tato C.M., and O'Shea J.J. Immunology: what does it mean to be just 17. Nature 441 (2006) 166-168
35. Weaver C.T., Harrington L.E., Mangan P.R., Gavrieli M., and Murphy K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24 (2006) 677-688
36. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
37. Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol 6 (2006) 329-333
38. Li G.Z., Zhong D., Yang L.M., Sun B., Zhong Z.H., Yin Y.H., et al. Expression of interleukin-17 in ischemic brain tissue. Scand J Immunol 62 (2005) 481-486
39. Villarino A.V., Larkin, Saris III C.J., Caton A.J., Lucas S., Wong T., et al. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol 174 (2005) 7684-7691
40. Pflanz S., Hibbert L., Mattson J., Rosales R., Vaisberg E., Bazan J.F., et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 172 (2004) 2225-2231